UCI awarded $3.5 million for stem cell research

February 16, 2007

Irvine, Calif., February 16, 2007 -- UC Irvine scientists were awarded $3.5 million in the first wave of stem cell research funding from the California Institute for Regenerative Medicine (CIRM), its governing board decided today.

Six UCI projects - with focuses ranging from muscular dystrophy to mitochondria - were selected by the Independent Citizens Oversight Committee (ICOC) for two-year Scientific Excellence through Exploration and Development (SEED) grants.

"CIRM support of UCI faculty underscores the strength of stem cell research in our institution," said Hans Keirstead, co-director of UCI's Sue and Bill Gross Stem Cell Research Center. "UCI is unique in having a large number of both basic stem cell researchers and individuals skilled in translating basic discoveries to the clinic. These qualities are essential for speeding basic discoveries to the clinic."

The ICOC approved about $45 million for 72 projects intended to bring new ideas and new investigators to the field of human embryonic stem cell research. The grants were selected from 231 applications from 36 California institutions totaling more than $138.3 million. Grant funding is subject to review and modification by CIRM.

The six UCI scientists:

Vincent Procaccio, assistant professor of pediatrics, was awarded $623,500 to study the role of mitochondria in enabling human embryonic stem cells to develop into desired cell types. Mitochondria, which have their own DNA, are the power plants that create energy for cells. Procaccio plans to create human embryonic stem cells with mitochondrial DNA mutations that cause human disease and examine their growth into neurons. His goal is to help determine if the ability of human embryonic stem cells to generate into desired cell types declines due to mitochondrial dysfunction. If this hypothesis is confirmed, procedures for protecting mitochondria will be developed to greatly increase the therapeutic potential of human embryonic stem cells.

Kyoko Yokomori, associate professor of biological chemistry, was awarded $623,500 to study the chromatin structure formed at DNA sequences linked to a form of muscular dystrophy. She plans to develop human embryonic stem cells associated with the disorder and compare them to normal human embryonic stem cells during skeletal muscle differentiation. The research is expected to further scientific understanding of the origin and physical progression of the condition as well as to possibly develop therapies for patients suffering from the disorder.

Grant MacGregor, associate professor of developmental and cell biology, was awarded $623,781 to identify ways that female reproductive cells can be grown from human embryonic stem cells. Methods to generate embryonic stem cells that are compatible with a patient's immune system usually involve the transfer of the nucleus from a patient's cell into a donated human egg cell from which the genetic information has been removed. Because of a shortage of donated human egg cells available for biomedical research, an urgent need to identify alternative sources exists.

Charles Limoli, associate professor of radiation oncology, was awarded $625,617 to use human embryonic stem cells to replace somatic stem cells depleted during the course of cancer radiotherapy. The goal will be to hasten the recovery of irradiated tissue. He also plans to assess the risk of tumor growth when human embryonic stem cells are implanted into healthy tissue or when tissue is compromised by irradiation. Understanding the cancer risks associated with the therapeutic use of human embryonic stem cells is poorly understood and critical for the field to move forward.

Thomas Lane, professor of molecular biology and biochemistry, was awarded $425,594 to better understand how to repair the nervous system damage that occurs in diseases such as multiple sclerosis. Lane plans to evaluate the potential of stem cells in initiating and maintaining repair of diseased nerve tissue with the goal of treating humans.

Brian Cummings, assistant professor of physical medicine and rehabilitation, was awarded $619,223 to better understand the effect of immunosuppressive agents on stem cell proliferation in the central nervous system. Stem cell therapies hold great promise for the treatment of a wide range of diseases, but transplanting them into a patient often requires doctors to suppress a patient's immune system. Currently, transplanting multipotent stem cells into the injured central nervous system often results in poor cell survival.

The second round of CIRM research funding - up to $80 million over four years - is scheduled to be awarded in March. The ICOC plans to grant these funds to as many as 25 accomplished scientists with ongoing projects studying human embryonic stem cells.
-end-
UCI is at the forefront of stem cell research. It is home to the Sue and Bill Gross Stem Cell Research Center, which promotes basic and clinical research training in the field of stem cell biology. More than 60 UCI scientists use stem cells in their current or planned studies. These scientists study spinal cord injuries, brain injuries and central nervous system diseases such as multiple sclerosis, Alzheimer's and Huntington's.

About the University of California, Irvine: The University of California, Irvine is a top-ranked university dedicated to research, scholarship and community service. Founded in 1965, UCI is among the fastest-growing University of California campuses, with more than 25,000 undergraduate and graduate students and about 1,800 faculty members. The second-largest employer in dynamic Orange County, UCI contributes an annual economic impact of $3.7 billion. For more UCI news, visit www.today.uci.edu.

Television: UCI has a broadcast studio available for live or taped interviews. For more information, visit www.today.uci.edu/broadcast.

News Radio: UCI maintains on campus an ISDN line for conducting interviews with its faculty and experts. The use of this line is available free-of-charge to radio news programs/stations who wish to interview UCI faculty and experts. Use of the ISDN line is subject to availability and approval by the university.

UCI maintains an online directory of faculty available as experts to the media. To access, visit www.today.uci.edu/experts.

University of California - Irvine

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.